News By Tag Industry News News By Location Country(s) Industry News
| Preeclampsia May Indicate Future HypothyroidismThyroid disease is a disorder that often manifests itself initially during pregnancy. It is the second most common endocrine disorder for women of childbearing age. Approximately 4% to 10% of non-pregnant women have sub-clinical hypothyroidism.
By: Dr Michele Brown OB/GYN Now that you understand (from these previous articles) that pregnancy sometimes serves as a “crystal ball” of future diseases in the mother, I want to give you another heads up. This time it’s about thyroid disease. Thyroid disease is an endocrinological disorder that often manifests itself initially during pregnancy. It is the second most common endocrine disorder for women of childbearing age. In the general population, approximately 4% to 10% of non-pregnant women have sub-clinical hypothyroidism. What is subclinical hypothyroidism? The production of thyroid hormone is regulated by the pituitary gland in the brain which secretes thyroid stimulating hormone (TSH). This hormone travels to the thyroid gland and stimulates the production of thyroid hormone. When a patient has increased TSH in conjunction with a thyroid hormone level within the normal range, this is often referred to as “subclinical hypothyroidism.” What are the changes that occur in pregnancy? The thyroid gland sometimes increases in size during pregnancy. Iodide levels decrease during pregnancy because of fetal use of iodide. Therefore, it is recommended by the World Health Organization that pregnant women take 200 micrograms per day as a replacement. The level of thyroid stimulating hormone is generally decreased in the first trimester, which has minimal clinical effects. TSH levels then normalize by second trimester. How does preeclampsia effect the thyroid gland? There is new consideration being given to the possibility that vascular damage after preeclampsia may affect the thyroid gland causing subclinical hypothyroidism. It has been proposed that this may be independent of the autoimmune process to which hypothyroidism is usually attributed. In preeclampsia, the serum concentration of thyroid stimulating hormone is increased. This may cause subclinical hypothyroidism. Studies have shown that TSH levels sometimes increase 2.42 times above baseline in women with preeclampsia. Studies of women with preeclampsia have shown that those women are also more likely than a control group of women who do not have preeclampsia, to develop a raised TSH concentration about 20 years later. This raises the possibility that subclinical hypothyroidism is more common after preeclampsia and that women with a history of preeclampsia may even have an elevated risk of reduced thyroid function as they get older. These thyroid findings may also contribute to the hypertension and coronary artery disease that has been found to occur in people who have had preeclampsia. Treatment with thyroxine may possibly reduce future cardiovascular risk. It may be advisable to screen women who have had preeclampsia for thyroid function after they deliver, with ongoing follow-ups. Treatment with thyroxine may prove to be beneficial in the prevention of early cardiovascular disease in affected women. SUMMARY: Preeclampsia can cause reduced thyroid function during pregnancy and can be an indicator of which women would be more prone to developing reduced thyroid function in later years. Women who have had preeclampsia are advised to be followed by the their physicians after their pregnancy has ended. Stay healthy, all you mothers out there! Pay attention to what your pregnancy tells you. # # # Coldfire Inc. specializes in Search Engine Optimization, Search Engine Marketing, e-mail marketing, newsletter marketing, social media marketing, advertising, PR and Reputation Management. We build CMS Websites and e-commerce shopping carts. Please visit http://www.beautedemaman.com Submitted by Coldfire Inc. http://www.coldfireinc.com End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||